An interventional study of Pressure release and Non emision Laser in Manual Therapy, Myofascial Pain Syndrome and Foot, sponsored by Mayuben Private Clinic. Completed at 1 site in Spain. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-06.
Sponsored by Mayuben Private Clinic · Not applicable, Interventional, and Other
In this study we will test the effects of pressure release on the Flexor digitorum brevis muscle on the plantar pressures variables using a pressure platform.
1,142 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.
This study's enrollment of 36 is below the median of 60 across 937 interventional studies indexed under Myofascial Pain Syndromes.
Browse Myofascial Pain Syndromes studies →Mayuben Private Clinic is the lead sponsor of 22 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Application of pressure release as a trigger point treatment of the flexor digitorum brevis muscle. Performing 3 pressure cycles until the disappearance of the referred pain for a minimum of 90 seconds.
Other: Pressure release
Application of a non-emitting laser for 5 minutes.
Other: Non emision Laser
Release of pre-pressure at the latent trigger point of flexor digitorum brevis
Non emision laser in Flexor digitorum brevis latent trigger point
Variables of plantar pressures with platform before non-emission laser
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Time frame: Through study completion, an average of 2 days
Variables of plantar pressures with platform before pressure release
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Time frame: Through study completion, an average of 2 days
Variable footprint planting surface with platform before non-emission laser
For 30 seconds we will record the area of the footprint in square centimetres.
Time frame: Through study completion, an average of 2 days
Variable footprint plantar surface with platform before pressure release
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Time frame: Through study completion, an average of 2 days
Variables of plantar pressures with platform after non-emission laser
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Time frame: Through study completion, an average of 2 days
Variables of plantar pressures with platform after preassure release
For 30 seconds we will record the plantar pressure variables in grams per square centimetre.
Time frame: Through study completion, an average of 2 days
Variable footprint planting surface with platform after non-emission laser
For 30 seconds we will record the area of the footprint in square centimetres.
Time frame: Through study completion, an average of 2 days
Variable footprint planting surface with platform after pressure release
For 30 seconds we will record the area of the footprint in square centimetres.
Time frame: Through study completion, an average of 2 days
Ran from Jul 2024 to primary completion in Jul 2024, 0 months.
Of 455 non-industry interventional studies with no phase under Myofascial Pain Syndromes, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 20. This study's 0 months is below that.
Counting every sponsor, half of 466 studies reached it within 9 months; a quarter within 3 and three quarters within 20.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mayuben Private Clinic